Karyopharm Therapeutics, Inc. (KPTI)
7.00
+0.52
(+8.02%)
USD |
NASDAQ |
Dec 11, 16:00
7.01
+0.01
(+0.14%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Investing (Quarterly): 4.805M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 46.36M |
| Actinium Pharmaceuticals, Inc. | 0.00 |
| Axsome Therapeutics, Inc. | -0.058M |
| Krystal Biotech, Inc. | -4.286M |
| Akebia Therapeutics, Inc. | -0.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.86M |
| Free Cash Flow | -89.30M |
| Free Cash Flow Per Share (Quarterly) | -0.676 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | 5.159M |
| Free Cash Flow Yield | -149.4% |